A cancer drug shows promise, at a price that many can't pay.
Berenson
Alex
A
D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy*; D003110:Colonic Neoplasms / Q000188:drug therapy; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D005260:Female; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008175:Lung Neoplasms / Q000188:drug therapy*; D035703:Therapies, Investigational / Q000191:economics*; D014481:United States
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab